IDH2 and cholangiocarcinoma: For example, loss of PTF1A, a master regulator of pancreatic acinar differentiation, is a rate-limiting step for pancreatic tumor development (103), while mutations in IDH promote cholangiocarcinoma by interfering with the differentiated state of hepatocytes (104).